
Studies support potential treatment for obesity-related disorders
Positive results from multiple in vivo studies have shown the impact of sphingosine kinase-2 (SPHK2) inhibition in various models of metabolic disease. RedHill Biopharma announced the positive study results, which show the effect of opaganib on weight gain and glucose tolerance in a high fat diet… Read More












